Jam. Tafani et al., IN-VIVO BINDING OF [I-125] NH2-CARFENTANIL TO MU-OPIOID RECEPTORS IN MOUSE-BRAIN, Nuclear medicine and biology, 21(2), 1994, pp. 231-238
A functionalized derivative of the mu opioid agonist carfentanil was s
ynthesized (NH2-carfentanil) and showed high specific activity when ra
diolabeled with iodine. [I-127]NH2-carfentanil displayed high affinity
and pronounced mu-binding selectivity with a delta/mu selectivity rat
io of over 1200. The ability of [I-125]NH2- carfentanil to interact in
vivo with opioid receptors was determined in mouse brain using ex viv
o binding techniques. Twenty minutes after intraperitoneal injection,
0.1% of the [I-125]NH2-carfentanil injected into the mouse was present
in the brain. [I-125]NH2-carfentanil specific binding was inhibited b
y co-injection of naloxone or morphine while naltrindole, a delta-sele
ctive antagonist, was unable to displace the bound radioligand. Autora
diographic experiments revealed a heterogeneous distribution of [I-125
]NH2-carfentanil specific binding sites, maximal binding occurred in a
reas with high densities of mu receptors. Peripherally administered io
do-NH2-carfentanil selectively labelled central mu opioid receptors in
mouse indicating great potential for single photon emission computed
tomography studies.